We are live on ! Find out more
CF

Cantor Fitzgerald Portfolio holdings

AUM $6.78B
1-Year Est. Return 29.01%
This Fund
S&P 500
This Quarter Est. Return
+15.12%
1 Year Est. Return
+29.01%
3 Year Est. Return
+173.81%
5 Year Est. Return
10 Year Est. Return
AUM
$487M
AUM Growth
-$3.25B
Cap. Flow
-$3.3B
Cap. Flow %
-678.55%
Top 10 Hldgs %
60.08%
Holding
635
New
80
Increased
47
Reduced
54
Closed
377

Top Buys

Rank Stock Value
1
XBP icon
XBP Global Holdings
XBP
+$91.7M
2
GSK icon
GSK
GSK
+$22.6M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$7.82M
4
CYTK icon
Cytokinetics
CYTK
+$7.14M
5
TSLA icon
Tesla
TSLA
+$6.42M

Sector Composition

Rank Sector Weight
1 Financials 21.01%
2 Technology 14.12%
3 Healthcare 12.63%
4 Communication Services 9.2%
5 Consumer Discretionary 7.67%

Similar funds

Cantor Fitzgerald's Q4 2023 Portfolio in Review

As of Q4 2023, Cantor Fitzgerald held 635 positions worth $487M, down 87% from $3.74B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Cantor Fitzgerald withdrew a net $3.3B in Q4 2023, closing 377 positions and reducing 54 holdings. Its most notable exit was Apple, an estimated $98.7M position sold in full.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 13% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Cantor Fitzgerald opened a new position in XBP Global Holdings worth $35M.

  • Cantor Fitzgerald's largest Q4 2023 buy was XBP Global Holdings: 660,190 shares worth $35M.
  • Cantor Fitzgerald added most to GSK in Q4 2023, an estimated $22.6M increase.
  • Cantor Fitzgerald's biggest Q4 2023 reduction was Microsoft, cutting an estimated $109M.
  • Cantor Fitzgerald fully exited Apple in Q4 2023, selling an estimated $98.7M.
  • Cantor Fitzgerald's ten largest holdings make up 60% of its $487M portfolio in Q4 2023.
  • Cantor Fitzgerald opened 80 new positions and closed 377 in Q4 2023.
  • Cantor Fitzgerald's portfolio value fell 87% quarter-over-quarter to $487M.

Based on Cantor Fitzgerald's 13F filing for Q4 2023, filed 14 Feb 2024.